Bluejay Diagnostics, Inc. balance sheet

At the end of fiscal 2022, Bluejay Diagnostics, Inc. had total assets of $13.5m, total liabilities of $2.0m and shareholders' equity of $11.5m. It held $10.1m in cash against $0 of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Bluejay Diagnostics, Inc.: balance sheet, annual
Fiscal year	2022Dec 2022
Cash and equivalents	10
Total current assets	12
Total assets	14
Accounts payable	1
Total current liabilities	2
Total debt	0
Total liabilities	2
Shareholders' equity	12
Shares outstanding	1m

US$ millions unless shown otherwise. Fiscal quarters.

Bluejay Diagnostics, Inc.: balance sheet, quarterly
Quarter	2022 Q2Jun 2022	2022 Q3Sept 2022	2022 Q4Dec 2022
Inventory	1	—	—
Total current assets	17	14	12
Total assets	18	16	14
Accounts payable	0	0	1
Total current liabilities	1	2	2
Total liabilities	1	2	2
Shareholders' equity	17	14	12
Shares outstanding	20m	20m	1m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Bluejay Diagnostics, Inc.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Bluejay Diagnostics, Inc.